Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1995 1
1996 2
1998 3
1999 2
2000 1
2001 6
2002 5
2003 4
2004 4
2005 9
2006 9
2007 7
2008 17
2009 13
2010 21
2011 16
2012 10
2013 25
2014 20
2015 18
2016 19
2017 17
2018 18
2019 11
2020 6
2021 13
2022 9
2023 14
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Results by year

Filters applied: . Clear all
Page 1
Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study.
Straatmijer T, Biemans VBC, Visschedijk M, Hoentjen F, de Vries A, van Bodegraven AA, Bodelier A, de Boer NKH, Dijkstra G, Festen N, Horjus C, Jansen JM, Jharap B, Mares W, van Schaik FDM, Ponsioen C, Romkens T, Srivastava N, van der Voorn MMPJA, West R, van der Woude J, Wolvers MDJ, Pierik M, van der Meulen-de Jong AE, Duijvestein M; Initiative on Crohn and Colitis. Straatmijer T, et al. Among authors: van bodegraven aa. Clin Gastroenterol Hepatol. 2023 Jan;21(1):182-191.e2. doi: 10.1016/j.cgh.2022.04.038. Epub 2022 May 26. Clin Gastroenterol Hepatol. 2023. PMID: 35644343 Free article.
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial.
Ponsioen CY, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Bossuyt PMM, Hart A, Warusavitarne J, Buskens CJ, van Bodegraven AA, Brink MA, Consten ECJ, van Wagensveld BA, Rijk MCM, Crolla RMPH, Noomen CG, Houdijk APJ, Mallant RC, Boom M, Marsman WA, Stockmann HB, Mol B, de Groof AJ, Stokkers PC, D'Haens GR, Bemelman WA; LIR!C study group. Ponsioen CY, et al. Among authors: van bodegraven aa. Lancet Gastroenterol Hepatol. 2017 Nov;2(11):785-792. doi: 10.1016/S2468-1253(17)30248-0. Epub 2017 Aug 31. Lancet Gastroenterol Hepatol. 2017. PMID: 28838644 Clinical Trial.
Clinical nutrition in the hepatogastroenterology curriculum.
Mulder CJ, Wanten GJ, Semrad CE, Jeppesen PB, Kruizenga HM, Wierdsma NJ, Grasman ME, van Bodegraven AA. Mulder CJ, et al. Among authors: van bodegraven aa. World J Gastroenterol. 2016 Feb 7;22(5):1729-35. doi: 10.3748/wjg.v22.i5.1729. World J Gastroenterol. 2016. PMID: 26855532 Free PMC article. Review.
Mercaptopurine for the Treatment of Ulcerative Colitis: A Randomized Placebo-Controlled Trial.
Löwenberg M, Volkers A, van Gennep S, Mookhoek A, Montazeri N, Clasquin E, Duijvestein M, van Bodegraven A, Rietdijk S, Jansen J, van Asseldonk D, van der Zanden E, Dijkgraaf M, West R, de Boer N, D'Haens G. Löwenberg M, et al. Among authors: van bodegraven a. J Crohns Colitis. 2023 Jul 5;17(7):1055-1065. doi: 10.1093/ecco-jcc/jjad022. J Crohns Colitis. 2023. PMID: 36847130 Free PMC article. Clinical Trial.
Editorial: nocebo effect and switching to biosimilars.
van Bodegraven AA, Boone NW. van Bodegraven AA, et al. Aliment Pharmacol Ther. 2018 Mar;47(6):850-851. doi: 10.1111/apt.14509. Aliment Pharmacol Ther. 2018. PMID: 29446141 No abstract available.
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial.
van Linschoten RCA, Jansen FM, Pauwels RWM, Smits LJT, Atsma F, Kievit W, de Jong DJ, de Vries AC, Boekema PJ, West RL, Bodelier AGL, Gisbertz IAM, Wolfhagen FHJ, Römkens TEH, Lutgens MWMD, van Bodegraven AA, Oldenburg B, Pierik MJ, Russel MGVM, de Boer NK, Mallant-Hent RC, Ter Borg PCJ, van der Meulen-de Jong AE, Jansen JM, Jansen SV, Tan ACITL, van der Woude CJ, Hoentjen F; LADI study group and the Dutch Initiative on Crohn and Colitis. van Linschoten RCA, et al. Among authors: van bodegraven aa. Lancet Gastroenterol Hepatol. 2023 Apr;8(4):343-355. doi: 10.1016/S2468-1253(22)00434-4. Epub 2023 Jan 31. Lancet Gastroenterol Hepatol. 2023. PMID: 36736339 Clinical Trial.
Perspective on skeletal health in inflammatory bowel disease.
van Bodegraven AA, Bravenboer N. van Bodegraven AA, et al. Osteoporos Int. 2020 Apr;31(4):637-646. doi: 10.1007/s00198-019-05234-w. Epub 2019 Dec 10. Osteoporos Int. 2020. PMID: 31822927 Free PMC article. Review.
COVID-19 in the IBD Population: The Need for Correct Nomenclature.
Rezazadeh Ardabili A, Creemers RH, van Bodegraven AA. Rezazadeh Ardabili A, et al. Among authors: van bodegraven aa. J Crohns Colitis. 2021 May 4;15(5):872-873. doi: 10.1093/ecco-jcc/jjaa222. J Crohns Colitis. 2021. PMID: 33119740 Free PMC article. No abstract available.
269 results